Premium
Oral post‐radiation malignant fibrous histiocytoma: a clinicopathological study
Author(s) -
Lin SzeKwan,
How ShuWen,
Wang JengTzung,
Liu BuYuan,
Chiang ChunPin
Publication year - 1994
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/j.1600-0714.1994.tb00069.x
Subject(s) - medicine , radiation therapy , tongue , malignancy , mandible (arthropod mouthpart) , lesion , maxilla , floor of mouth , nasopharyngeal carcinoma , soft tissue , carcinoma , radiography , metastasis , radiology , surgery , pathology , dentistry , cancer , biology , genus , botany
Five cases of oral malignant fibrous histiocytoma (MFH) in patients who had previously received radiotherapy in the head or neck region were included in this study. There were 3 men and 2 women. Four patients had been irradiated for nasopharyngeal carcinoma (NPC) and the other for a squamous cell carcinoma (SCC) involving the tongue and mouth floor. The MFH developed 2.5–11 years after the initial radiotherapy. Two cases of MFH occurred in the maxilla, two in the mandible, and the remaining one in the tongue, floor of mouth and mandible. Clinically, the oral post‐radiation MFH presented as tender, reddish, elastic, lobulated masses with surface ulceration. Radiographic examination of the involved jaws revealed a poorly defined radiolucent lesion without any periosteal or endosteal reaction. The prognosis of these tumors was very poor. Although aggressive multimodality treatment had been applied, 3 of 5 patients eventually died of the disease, with a mean survival time of 17 months after establishing the diagnosis of MFH. In order to ensure the early diagnosis and treatment of this radiation‐induced second malignancy, close oral follow‐up is mandatory for patients who have received radiotherapy for head and neck malignancies.